我们简要回顾了现有的高复合蛋白质组技术在癌症液体活检方面的最新进展,并总结了这一应用的优点和缺点(表1)。从临床转化的角度来看,由于目前使用的基于癌症液体活检的蛋白质组生物标志物只有不到40种,(https://www.cancer.gov/about-...
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors. Tumour Biol 2003;24:209-18....
Tumor markers in pancreatic cancer: a European Group on Tumor Markers(EGTM) status report [J]. Oncol, 2010,21(3):441-447.Duffy MJ, Sturgeon C, ... O Segurado,J Bonfrer,M Duffy,... - 《Anticancer Research》 被引量: 357发表: 1999年 Clinical use of biomarkers in breast cancer: Upda...
2) Mean values of these markers in portal blood were higher than those in peripheral blood. 3) Portal blood CEA was correlated with Dukes' staging, and revealed higher positive rates than CEA in peripheral blood in each stage. Portal CA19-9 changed within normal value and strikingly rose in...
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol. 2010; 21: 441- 7. https://doi.org/10.1093/annonc/mdp332.Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, Klapdor R, Nicolini A, Topolcan O, Heinemann V (2010) Tumor ...
The VIDAS® panel of Tumour Markers offers a fast, automated, precise, and reliable solution to meet your diagnostic needs. View Product VIDAS® 3 Trusted. Robust. Innovative. With its advanced immunoassay technology and optimized testing protocols, the fully automated VIDAS® 3 benchtop i...
Purpose of Review The purpose of this review is to update readers on recent findings about serum tumor markers in clinical settings of endometrial cancer. Recent Findings The latest research on this topic discussed risk factors of pelvic lymph node metastasis and levels of two serum tumor markers ...
Colonic NeoplasmsCell Adhesion MoleculesReceptors, Cell SurfaceTumor Markers, BiologicalAdultRecombinant human gamma 2 chain of laminin-5 was expressed in ... C Pyke,S Salo,E Ralfkiær,... - 《Cancer Research》 被引量: 906发表: 1995年 Prognostic significance of defective mismatch repair and ...
Unlike healthy tissues, tumours thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despite being a well-known cause of therapy resistance and metastasis, the impact of low oxygen, kno
42% were between 0-2.5 ng/ml; 36% between 2.6- 5.0 ng/ml; 15% between 5.1 - 10 ng/ml and 7% had values greater than 10ng/ml. The percent elevations in pulmonary emphysema were higher than inany other benign disease included in the study except for the 156Human Tumor Markers© 19...